Big Pharma has aimed some choice words at European countries in recent weeks, including calling the UK “uninvestable” and warning that the region as a whole is fast losing its edge to China.
Yet even as Europe is buffeted by change — the clamor for Chinese biotech or, more recently, the rush to appease US President Donald Trump — one country is showing there could still be a way to build up a pharmaceutical industry: by giving companies what they want.
Share this article with your
friends and colleagues.
Earn points from views and
referrals who sign up.
Learn more